Galmed Pharmaceuticals
GLMD • NASDAQ
Galmed Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Allen Baharaff, with a market cap of $5.2M.
Market Cap$5.2M
Employees8.0
CEOAllen Baharaff
CountryIsrael
Healthcare
Biotechnology
Next EarningsMay 21, 2026 · in a monthQ1 2026
Financials
Galmed Pharmaceuticals FAQ
Common questions about Galmed Pharmaceuticals
Galmed Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 21, 2026.
Galmed Pharmaceuticals has approximately 8 employees.